200 related articles for article (PubMed ID: 7967705)
21. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations.
Tricot G; Boogaerts MA; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 Apr; 59(4):659-70. PubMed ID: 3857071
[TBL] [Abstract][Full Text] [Related]
22. Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years.
De Witte T; Muus P; De Pauw B; Haanen C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():33-5. PubMed ID: 2697396
[TBL] [Abstract][Full Text] [Related]
23. Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome.
Martiat P; Ferrant A; Michaux JL; Sokal G
Hematol Oncol; 1988; 6(4):299-305. PubMed ID: 3181878
[TBL] [Abstract][Full Text] [Related]
24. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial.
Hoyle CF; de Bastos M; Wheatley K; Sherrington PD; Fischer PJ; Rees JK; Gray R; Hayhoe FG
Br J Haematol; 1989 May; 72(1):45-53. PubMed ID: 2736242
[TBL] [Abstract][Full Text] [Related]
25. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.
De Witte T; Muus P; De Pauw B; Haanen C
Cancer; 1990 Sep; 66(5):831-7. PubMed ID: 2386911
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
Kuriyama K
Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
[TBL] [Abstract][Full Text] [Related]
28. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
[TBL] [Abstract][Full Text] [Related]
29. Idarubicin in combination with cytarabine and VP-16 in the treatment of post myelodysplastic syndrome acute myeloblastic leukemia (MDS-AML).
Pogliani EM; Baldicchi L; Pioltelli P; Miccolis IR; Mangiagalli M; Corneo GM
Leuk Lymphoma; 1995 Nov; 19(5-6):473-7. PubMed ID: 8590849
[TBL] [Abstract][Full Text] [Related]
30. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
31. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).
de Witte T; Suciu S; Peetermans M; Fenaux P; Strijckmans P; Hayat M; Jaksic B; Selleslag D; Zittoun R; Dardenne M
Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
Ribrag V; Suzan F; Ravoet C; Feremans W; Guerci A; Dreyfus F; Damaj G; Vantelon JM; Bourhis JH; Fenaux P
Leukemia; 2003 Feb; 17(2):319-22. PubMed ID: 12592329
[TBL] [Abstract][Full Text] [Related]
33. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
[TBL] [Abstract][Full Text] [Related]
34. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
35. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
Ito T; Ohashi H; Kagami Y; Ichikawa A; Saito H; Hotta T
Leukemia; 1994 May; 8(5):839-43. PubMed ID: 7910221
[TBL] [Abstract][Full Text] [Related]
36. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
37. A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia.
Hellström-Lindberg E; Robèrt KH; Gahrton G; Lindberg G; Forsblom AM; Kock Y; Ost A
Br J Haematol; 1992 Aug; 81(4):503-11. PubMed ID: 1390236
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].
Su JY; Chang CK; Zhang X; Zhou LY; Song LQ; Xu L; Wu LY; He Q; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):459-63. PubMed ID: 19379588
[TBL] [Abstract][Full Text] [Related]
39. [Low-dose chemotherapy].
Ogata K; Yamada T; Dan K
Rinsho Ketsueki; 1996 Sep; 37(9):777-81. PubMed ID: 8914461
[TBL] [Abstract][Full Text] [Related]
40. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse.
Nagai K; Matsuo T; Atogami S; Moriuchi Y; Yoshida Y; Kuriyama K; Tomonaga M
Br J Haematol; 1992 May; 81(1):33-9. PubMed ID: 1520622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
